HealthcareServices

Global Cell And Gene Therapy Clinical Trial Services Market Forecast 2026–2035: Long-Term Growth Insights

March 2, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the cell and gene therapy clinical trial services market from 2026–2035 with trusted insights from The Business Research Company

What market expansion outlook does the Cell And Gene Therapy Clinical Trial Services Market show for the 2026–2030 period?

The size of the cell and gene therapy clinical trial services market has expanded significantly in recent years. This market is projected to expand from $4.18 billion in 2025 to $4.62 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.3%. Historically, this growth is a result of an increasing number of cell and gene therapy clinical trials, a rise in outsourcing to specialized cros, the growing complexity of trial designs, the expansion of rare disease research, and stricter regulatory oversight for advanced therapies.

The cell and gene therapy clinical trial services market is projected to experience robust expansion over the coming years, reaching a valuation of $6.44 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.7%. This anticipated growth throughout the forecast period stems from factors such as a heightened demand for late-stage clinical trial services, the increasing uptake of digital trial technologies, the broader implementation of global patient recruitment initiatives, an intensified focus on incorporating real-world evidence, and greater financial commitments to precision clinical research. Key developments expected during the forecast timeframe encompass a rising embrace of decentralized clinical trial models, the expanded utilization of digital platforms for patient recruitment, the progressive integration of sophisticated data management systems, the broadening of global trial site networks, and a heightened emphasis on adhering to regulatory standards and ensuring trial accuracy.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15535&type=smp

What Drivers Are Shaping The Development Of The Cell And Gene Therapy Clinical Trial Services Market?

The increasing occurrence of genetic disorders is anticipated to fuel the expansion of the cell and gene therapy clinical trial services market in the future. These conditions stem from alterations in an individual’s DNA or genetic makeup. Several factors contribute to the growing frequency of genetic diseases, such as enhanced access to genetic testing, the emergence of genetic mutations, and the commonness of marriages between relatives. Cell and gene therapy clinical trial services tackle the increasing prevalence of genetic diseases by fostering new treatment development, customizing therapies for specific patients, speeding up the application of research in clinical settings, and broadening the choices for individuals affected by genetic disorders. For example, in 2023, data from the National Health Service, a UK government body, indicated that sickle cell disorder (SCD) is England’s most common genetic condition, affecting approximately 17,000 individuals (NHSE, 2023). Consequently, the growing incidence of genetic diseases is a key factor boosting the cell and gene therapy clinical trial services market’s growth.

Which Segments Are Contributing To The Growth Of The Cell And Gene Therapy Clinical Trial Services Market?

The cell and gene therapy clinical trial services market covered in this report is segmented –

1) By Service: Clinical Trial Design And Planning, Supply And Logistic Services, Regulatory Affairs And Compliance, Data Management And Biostatics, Site Management And Monitoring, Other Services

2) By Therapy Type: Gene Therapy, Cell Therapy, Gene Modified Cell Therapy

3) By Indication: Oncology, Hematology, Metabolic Disorders, Infectious Diseases, Neurology, Cardiovascular Diseases, Musculoskeletal Disorders, Other Indications

4) By End-Use: Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Academic And Research Institutes, Other End-Users

Subsegments:

1) By Clinical Trial Design And Planning: Protocol Development, Trial Feasibility Studies, Trial Design Consultation, Patient Recruitment And Enrollment Strategy, Risk-Based Monitoring Plans

2) By Supply And Logistic Services: Clinical Trial Supply Chain Management, Cold Chain Logistics, Packaging And Labeling Services, Transportation And Distribution Of Biological Samples, Customs And Import/Export Services

3) By Regulatory Affairs And Compliance: Regulatory Strategy And Consulting, Regulatory Submission And Documentation, Compliance With GMP (Good Manufacturing Practices), Regulatory Pathway Consultation, Clinical Trial Applications (CTAs)

4) By Data Management And Biostatistics: Clinical Data Management (CDM), Statistical Analysis And Reporting, Clinical Data Monitoring, Data Integration And Validation, Electronic Data Capture (EDC) Solutions

5) By Site Management And Monitoring: Site Selection And Initiation, Clinical Monitoring And Site Visits, Patient Recruitment And Retention, Site Training And Support, Site Performance Monitoring

6) By Other Services: Patient Advocacy And Engagement, Real-World Evidence (RWE) Studies, Post-Trial Services, Medical Writing And Documentation, Clinical Trial Auditing And Inspection

How Are New Market Trends Shaping The Landscape Of The Cell And Gene Therapy Clinical Trial Services Market?

Major companies operating in the cell and gene therapy clinical trial services market are concentrating their efforts on integrating advanced technology, particularly customer relationship management systems, to boost efficiency and gain a competitive advantage. The customer relationship management system utilized by cell and gene therapy clinical trial services streamlines and coordinates interactions with trial participants, healthcare providers, and other stakeholders throughout the clinical trial process. For instance, in April 2023, AmerisourceBergen Corporation, a US-based healthcare company, launched the Cell and Gene Therapy (CGT) Integration Hub, a platform intended to increase connectivity and streamline processes across the cell and gene therapy treatment pathway. This platform is supported by AmerisourceBergen’s customer relationship management (CRM) system and aims to simplify the path-to-care process, partly by providing physicians and patient services teams with improved visibility across the therapy development and delivery process. The CGT Integration Hub, which incorporates features such as expedited benefits investigation, real-time status tracking, and proactive alerts, seeks to simplify care coordination, minimize barriers, and enhance the overall patient and provider experience when delivering cell and gene therapies.

Who Are The Major Companies Operating In The Cell And Gene Therapy Clinical Trial Services Market?

Major companies operating in the cell and gene therapy clinical trial services market are Thermo Fisher Scientific Inc., Sharp Services LLC, IQVIA, Laboratory Corporation of America Holdings, ICON plc, Syneos Health Inc., Catalent Pharma Solutions Inc., Charles River Laboratories International Inc., Parexel International Corporation, PRA Health Sciences Inc., Covance Inc., Medpace Holdings Inc., BioClinica Inc., Precision Medicine Group LLC, Worldwide Clinical Trials LLC, Clinigen Group plc, Evidera Inc., Advarra LLC, Veristat LLC, Clinipace Inc., Celonic AG, Cromsource Inc., Novotech Pty Ltd., MedSource Holdings Inc., Frontage Laboratories Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/cell-and-gene-therapy-clinical-trial-services-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Cell And Gene Therapy Clinical Trial Services Market?

North America was the largest region in the cell and gene therapy clinical trial services market in 2025. It is expected to be the fastest-growing region in the forecast period. The regions covered in the cell and gene therapy clinical trial services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Cell And Gene Therapy Clinical Trial Services Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=15535&type=smp

Browse Through More Reports Similar to the Global Cell And Gene Therapy Clinical Trial Services Market 2026, By The Business Research Company

Cell And Gene Therapy Supply Chain Or Logistics Market Report 2026

https://www.thebusinessresearchcompany.com/report/cell-and-gene-therapy-supply-chain-or-logistics-global-market-report

Cell And Gene Therapy Manufacturing Services Market 2026

https://www.thebusinessresearchcompany.com/report/cell-and-gene-therapy-manufacturing-services-market

Genes Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/genes-therapy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795